You know but anybody is more interested in about obesity
Glucagon receptor activation is thought to increase energy expenditure and promote fat breakdown (lipolysis), which may help explain the substantial weight loss observed in early-phase trials however, these mechanistic effects have not yet been fully characterised in humans and should be regarded as preliminary findings
The use of GLP-1 agonists compared with bupropion-naltrexone was associated with increased risk of pancreatitis, bowel obstruction, and gastroparesis (a condition that slows or prevents the stomach from emptying its contents into the small intestine), but not biliary disease.8 Nutraceutical Compensation There are some nutraceuticals which may help compensate for some of the adverse effects associated with the use of GLP-1 agonist drugs

your diabetes team can advise whether you are eligible [9] Practical steps to reduce your risk include: Informing your healthcare team of all medications you are taking, including over-the-counter products and supplements Not skipping meals, even if your appetite is significantly reduced small, regular meals can help maintain stable glucose levels Carrying fast-acting glucose with you at all times Wearing a medical alert bracelet or carrying identification indicating your diabetes status and medications Avoiding excessive alcohol, which can impair the liver's ability to release glucose and mask hypoglycaemia symptoms [5] [6] Discussing any planned changes to diet or exercise with your care team before making them Driving safety is an important consideration if you are at risk of hypoglycaemia
Dosage forms Ozempic comes as an injection solution in a prefilled pen for subcutaneous injection (under the skin) to be given once a week